Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chakravarthi’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
Plans whose provider directory lists this clinician
Licensed to practise in California · since 2005 · expires 2028-09-30 · University of Madras, Kilpauk Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend it
Overall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits
4.5 (2.8 to 7) · 85 cases
No different
Jan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits
9.6 (6.7 to 13.7) · 85 cases
No different
Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits
5.7 · 189 cases
—None
Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits
11 · 45 cases
—None
Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits
20.6 · 117 cases
—None
Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits
13 (9.7 to 17.2) · 584 cases
No different
Jan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits
0.9 (0.7 to 1.2) · 764 cases
No different
Jan 2024 – Dec 2024
What patients said (523 patients answered, 27% of those asked)
Patient survey stars by topic at Peninsula Medical Center
Cleanliness
4
Nurse communication
4
Doctor communication
4
Communication about medicines
3
Discharge information
4
Overall hospital rating
4
Quietness
3
Recommend hospital
5
Share of patients giving the best answer at Peninsula Medical Center
Room was "always" clean
76%
Nurses "always" communicated well
81%
Doctors "always" communicated well
80%
Staff "always" explained
58%
Yes, staff "did" give patients this information
89%
Yes, staff "did" give patients information about help after discharge
87%
Doctors "always" explained things so they could understand
74%
Doctors "always" listened carefully
79%
Doctors "always" treated them with courtesy and respect
87%
Patients who gave a rating of "9" or "10" (high)
75%
Staff "always" explained new medications
72%
Nurses "always" explained things so they could understand
77%
Nurses "always" listened carefully
79%
Nurses "always" treated them with courtesy and respect
88%
"Always" quiet at night
54%
"YES", patients would definitely recommend the hospital
78%
Staff "always" explained possible side effects
44%
Yes, staff "did" give patients information about possible symptoms
90%
Original Medicare doctor bills
$177,588
Medicare paid this office $177,588 for 216 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Largest Original Medicare bills
Long return visit (40+ min)
92
$16,992
$162
Return visit (30+ min)
100
$11,310
$110
Who their Medicare patients are
216 Original Medicare patients in 2024. Average age 76 · Women 72% · Health risk score 1.51. At or below the middle of the specialty; the typical hematology clinician is at 2.35.
The office billed $517,793, Medicare allowed $226,520 and paid $177,588; for 5,444 services of 47 kinds; $142,816 of it was for drugs given in the office and $34,772 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
Original Medicare by year
2024
216
5,444
76
1.51
$517,793
$177,588
2023
518
59,641
77
1.37
$3,145,208
$1,003,510
2022
542
61,553
77
1.36
$3,495,440
$1,110,429
2021
556
78,520
77
1.37
$4,626,517
$1,455,960
2020
520
66,972
76
1.46
$4,160,096
$1,326,765
2019
616
83,216
76
1.55
$5,640,456
$1,754,696
2018
521
78,259
76
1.50
$4,525,223
$1,458,950
2017
468
65,106
76
1.64
$4,095,835
$1,344,983
2016
476
50,948
75
1.48
$3,584,614
$1,069,413
2015
454
41,080
74
1.33
$2,615,408
$789,090
2014
400
57,070
75
1.38
$3,322,276
$934,231
2013
311
28,183
74
1.44
$1,752,823
$473,999
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 25 services
Original Medicare services billed in 2023
Injection, daratumumab, 10 mg and hyaluronidase-fihj
11
$176,154
—None
Long return visit (40+ min)
168
$49,310
$163
Return visit (30+ min)
213
$30,170
$110
Administration of chemotherapy into vein, 1 hour or less
44
$10,742
$145
New patient visit (60+ min)
32
$6,722
$210
Leuprolide acetate (for depot suspension), 7.5 mg
11
$6,142
—None
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
76
$6,115
$67
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
16
$4,253
$80
New patient visit (45+ min)
22
$2,985
$136
Bcg live intravesical instillation, 1 mg
14
$2,367
—None
Injection, zoledronic acid, 1 mg
57
$1,814
—None
Instillation of anti-cancer drug into bladder
14
$1,711
$86
Short return visit (20+ min)
15
$1,262
$84
Injection of drug or substance into vein
28
$1,243
$38
Injection of additional new drug or substance into vein
26
$1,222
$17
Injection of drug or substance under skin or into muscle
28
$1,151
$14
Administration of chemotherapy into vein, each additional hour
15
$1,081
$30
Administration of additional new drug or substance into vein, 1 hour or less
11
$990
$71
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
14
$804
$37
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
11
$590
$31
Office for the evaluation and management of established patient that may not require presence of healthcare professional
15
$419
$25
Injection, dexamethasone sodium phosphate, 1 mg
15
$39
—None
Injection, ondansetron hydrochloride, per 1 mg
15
$27
—None
Injection, diphenhydramine hcl, up to 50 mg
14
$18
—None
Infusion, normal saline solution, 250 cc
29
$15
—None
2022: 26 services
Original Medicare services billed in 2022
Injection, pembrolizumab, 1 mg
11
$236,298
—None
Long return visit (40+ min)
193
$87,728
$166
Return visit (30+ min)
251
$43,116
$109
Administration of chemotherapy into vein, 1 hour or less
61
$16,891
$151
Leuprolide acetate (for depot suspension), 7.5 mg
19
$9,720
—None
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
75
$7,663
$74
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
13
$5,932
$84
New patient visit (60+ min)
25
$5,302
$212
New patient visit (45+ min)
27
$4,076
$151
Short return visit (20+ min)
34
$2,764
$69
Administration of additional new drug or substance into vein, 1 hour or less
20
$2,488
$73
Drawing of blood for a medical problem
11
$2,267
$108
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
28
$2,150
$32
Administration of chemotherapy into vein, each additional hour
23
$2,046
$31
Injection of additional new drug or substance into vein
35
$1,904
$17
Injection, zoledronic acid, 1 mg
49
$1,457
—None
Instillation of anti-cancer drug into bladder
11
$1,433
$90
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
22
$1,067
$36
Injection of drug or substance into vein
22
$1,023
$41
Injection of drug or substance under skin or into muscle
30
$914
$15
Injection, fosaprepitant, 1 mg
13
$576
—None
Office for the evaluation and management of established patient that may not require presence of healthcare professional
15
$561
$24
Collection of blood sample from implanted device
11
$450
$28
Injection, dexamethasone sodium phosphate, 1 mg
33
$74
—None
Injection, ondansetron hydrochloride, per 1 mg
28
$47
—None
Injection, diphenhydramine hcl, up to 50 mg
20
$29
—None
2021: 27 services
Original Medicare services billed in 2021
Return visit (30+ min)
294
$84,961
$114
Injection, infliximab, excludes biosimilar, 10 mg
11
$32,058
—None
Injection, denosumab, 1 mg
12
$30,229
—None
Administration of chemotherapy into vein, 1 hour or less
68
$26,753
$161
Long return visit (40+ min)
66
$21,267
$170
Short return visit (20+ min)
131
$13,607
$80
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
78
$11,143
$80
Leuprolide acetate (for depot suspension), 7.5 mg
17
$8,744
—None
Drawing of blood for a medical problem
17
$4,552
$120
New patient visit (45+ min)
26
$4,125
$159
Administration of additional new drug or substance into vein, 1 hour or less
19
$3,881
$78
Injection of additional new drug or substance into vein
47
$3,303
$18
Administration of chemotherapy into vein, each additional hour
30
$2,940
$33
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
32
$2,435
$34
Bcg live intravesical instillation, 1 mg
11
$2,196
—None
Injection of drug or substance under skin or into muscle
40
$1,755
$14
Injection, zoledronic acid, 1 mg
36
$1,614
—None
Instillation of anti-cancer drug into bladder
11
$1,566
$92
Administration of additional new drug or substance into vein using push technique
14
$1,534
$67
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
22
$1,470
$35
Injection of drug or substance into vein
15
$1,256
$45
New patient visit (30+ min)
11
$1,069
$97
Office for the evaluation and management of established patient that may not require presence of healthcare professional
30
$935
$24
Injection, paclitaxel, 1 mg
12
$624
—None
Injection, dexamethasone sodium phosphate, 1 mg
33
$117
—None
Injection, ondansetron hydrochloride, per 1 mg
29
$56
—None
Injection, diphenhydramine hcl, up to 50 mg
31
$55
—None
2020: 27 services
Original Medicare services billed in 2020
Return visit (30+ min)
293
$68,732
$99
Injection, denosumab, 1 mg
12
$45,700
—None
Administration of chemotherapy into vein, 1 hour or less
59
$22,137
$153
Short return visit (20+ min)
136
$12,720
$66
Leuprolide acetate (for depot suspension), 7.5 mg
12
$7,642
—None
Long return visit (40+ min)
38
$7,134
$140
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
55
$6,798
$76
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
11
$5,555
$85
Administration of chemotherapy into vein, each additional hour
30
$4,389
$32
New patient visit (45+ min)
24
$3,796
$158
Administration of additional new drug or substance into vein, 1 hour or less
18
$3,221
$73
Injection of additional new drug or substance into vein
49
$2,935
$17
Drawing of blood for a medical problem
11
$2,913
$112
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
21
$1,824
$33
New patient visit (30+ min)
18
$1,551
$86
Injection of drug or substance under skin or into muscle
33
$1,257
$14
Telephone medical discussion with physician, 11-20 minutes
17
$1,190
$66
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
15
$1,153
$23
Injection, zoledronic acid, 1 mg
24
$926
—None
Injection of drug or substance into vein
17
$847
$40
Influenza vaccine split virus, preservative free
11
$671
$61
Office for the evaluation and management of established patient that may not require presence of healthcare professional
24
$580
$21
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
14
$567
$33
Administration of influenza virus vaccine
11
$230
$21
Injection, dexamethasone sodium phosphate, 1 mg
28
$91
—None
Injection, ondansetron hydrochloride, per 1 mg
22
$44
—None
Injection, diphenhydramine hcl, up to 50 mg
26
$42
—None
2019: 31 services
Original Medicare services billed in 2019
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
11
$100,935
—None
Injection, infliximab, excludes biosimilar, 10 mg
18
$81,655
—None
Return visit (30+ min)
332
$76,380
$100
Injection, rituximab, 10 mg
11
$73,848
—None
Injection, denosumab, 1 mg
19
$66,766
—None
Administration of chemotherapy into vein, 1 hour or less
86
$41,286
$149
Long return visit (40+ min)
76
$13,851
$136
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
67
$12,005
$76
Leuprolide acetate (for depot suspension), 7.5 mg
13
$11,950
—None
Short return visit (20+ min)
113
$10,722
$65
Administration of chemotherapy into vein, each additional hour
49
$9,546
$31
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
11
$8,007
$84
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
32
$4,290
$32
New patient visit (45+ min)
27
$4,203
$156
Injection of additional new drug or substance into vein
54
$4,196
$17
Drawing of blood for a medical problem
14
$3,075
$106
Administration of additional new drug or substance into vein, 1 hour or less
15
$2,812
$72
Injection of drug or substance under skin or into muscle
42
$2,256
$17
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
17
$1,966
$22
Transfusion of blood or blood products
15
$1,597
$38
New patient visit (30+ min)
15
$1,559
$104
Injection, zoledronic acid, 1 mg
30
$1,497
—None
Injection of drug or substance into vein
21
$1,105
$41
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
18
$1,061
$32
Collection of blood sample from implanted device
19
$958
$27
Office for the evaluation and management of established patient that may not require presence of healthcare professional
36
$908
$23
Irrigation of implanted venous access drug delivery device
13
$525
$28
Injection, dexamethasone sodium phosphate, 1 mg
37
$193
—None
Injection, methylprednisolone sodium succinate, up to 125 mg
14
$93
—None
Injection, diphenhydramine hcl, up to 50 mg
28
$66
—None
Injection, ondansetron hydrochloride, per 1 mg
22
$66
—None
2018: 28 services
Original Medicare services billed in 2018
Injection, infliximab, excludes biosimilar, 10 mg
20
$108,429
—None
Injection, pegfilgrastim, 6 mg
13
$72,252
—None
Return visit (30+ min)
267
$66,649
$91
Injection, denosumab, 1 mg
11
$53,343
—None
Administration of chemotherapy into vein, 1 hour or less
83
$43,436
$148
Long return visit (40+ min)
72
$13,826
$129
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
65
$12,482
$75
Leuprolide acetate (for depot suspension), 7.5 mg
11
$9,129
—None
Cyclophosphamide, 100 mg
11
$9,028
—None
New patient visit (45+ min)
54
$7,841
$145
Administration of chemotherapy into vein, each additional hour
49
$6,738
$32
New patient visit (60+ min)
22
$4,211
$191
Short return visit (20+ min)
53
$4,077
$61
Injection of additional new drug or substance into vein
63
$4,060
$18
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
19
$3,219
$22
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
32
$2,785
$32
Administration of additional new drug or substance into vein, 1 hour or less
19
$2,345
$71
Injection of drug or substance under skin or into muscle
44
$2,240
$20
Administration of additional new drug or substance into vein using push technique
14
$1,649
$61
Injection of drug or substance into vein
21
$1,004
$46
Injection, zoledronic acid, 1 mg
17
$950
—None
Transfusion of blood or blood products
14
$942
$38
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
12
$694
$32
Office for the evaluation and management of established patient that may not require presence of healthcare professional
29
$626
$21
Collection of blood sample from implanted device
14
$463
$26
Injection, dexamethasone sodium phosphate, 1 mg
44
$180
—None
Injection, ondansetron hydrochloride, per 1 mg
30
$63
—None
Injection, diphenhydramine hcl, up to 50 mg
27
$35
—None
2017: 28 services
Original Medicare services billed in 2017
Injection, infliximab, excludes biosimilar, 10 mg
17
$137,234
—None
Return visit (30+ min)
248
$58,003
$92
Injection, denosumab, 1 mg
13
$45,805
—None
Administration of chemotherapy into vein, 1 hour or less
69
$22,536
$142
Long return visit (40+ min)
72
$18,724
$133
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
56
$8,969
$71
New patient visit (45+ min)
41
$6,190
$151
New patient visit (60+ min)
25
$4,746
$190
Administration of chemotherapy into vein, each additional hour
40
$3,643
$28
Injection of additional new drug or substance into vein
52
$3,381
$23
Administration of additional new drug or substance into vein, 1 hour or less
14
$2,827
$67
Injection of drug or substance under skin or into muscle
37
$2,782
$25
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
19
$2,419
$18
Short return visit (20+ min)
28
$2,146
$65
Injection of drug or substance into vein
21
$2,045
$58
Drawing of blood for a medical problem
11
$2,014
$106
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
22
$1,805
$31
Injection, zoledronic acid, 1 mg
20
$1,407
—None
Collection of blood sample from implanted device
16
$1,260
$25
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
11
$793
$33
Transfusion of blood or blood products
15
$742
$37
Office for the evaluation and management of established patient that may not require presence of healthcare professional
29
$722
$20
Injection, carboplatin, 50 mg
11
$593
—None
Injection, hydrocortisone sodium succinate, up to 100 mg
11
$174
—None
Injection, dexamethasone sodium phosphate, 1 mg
36
$89
—None
Infusion, normal saline solution, 250 cc
12
$83
—None
Injection, ondansetron hydrochloride, per 1 mg
24
$48
—None
Injection, diphenhydramine hcl, up to 50 mg
24
$26
—None
2016: 31 services
Original Medicare services billed in 2016
Injection, rituximab, 100 mg
14
$115,237
—None
Injection, infliximab, excludes biosimilar, 10 mg
21
$102,642
—None
Injection, pegfilgrastim, 6 mg
19
$92,568
—None
Injection, bortezomib, 0.1 mg
11
$77,293
—None
Return visit (30+ min)
274
$61,568
$94
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
11
$46,524
—None
Long return visit (40+ min)
85
$28,515
$133
Administration of chemotherapy into vein, 1 hour or less
70
$19,716
$139
Leuprolide acetate (for depot suspension), 7.5 mg
14
$12,364
—None
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
42
$7,187
$71
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
14
$5,897
$77
New patient visit (45+ min)
38
$5,716
$150
New patient visit (60+ min)
27
$5,115
$189
Injection of drug or substance into vein
41
$3,954
$58
Injection of additional new drug or substance into vein
60
$3,881
$23
Injection of drug or substance under skin or into muscle
46
$3,798
$25
Administration of chemotherapy into vein, each additional hour
32
$2,494
$28
Administration of additional new drug or substance into vein, 1 hour or less
15
$2,367
$64
Injection, zoledronic acid, 1 mg
22
$2,078
—None
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
12
$1,719
$18
Drawing of blood for a medical problem
11
$1,681
$105
Short return visit (20+ min)
21
$1,480
$62
Transfusion of blood or blood products
23
$1,242
$37
Infusion into a vein for hydration, each additional hour
12
$1,043
$15
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
21
$1,018
$32
Office for the evaluation and management of established patient that may not require presence of healthcare professional
25
$588
$20
Injection, dexamethasone sodium phosphate, 1 mg
42
$85
—None
Infusion, normal saline solution, 250 cc
15
$84
—None
Injection, furosemide, up to 20 mg
20
$77
—None
Injection, ondansetron hydrochloride, per 1 mg
22
$46
—None
Injection, diphenhydramine hcl, up to 50 mg
24
$30
—None
2015: 31 services
Original Medicare services billed in 2015
Injection, infliximab, excludes biosimilar, 10 mg
23
$102,400
—None
Injection, rituximab, 100 mg
16
$88,574
—None
Return visit (30+ min)
250
$60,790
$97
Injection, pegfilgrastim, 6 mg
11
$48,995
—None
Administration of chemotherapy into vein, 1 hour or less
80
$23,855
$145
Long return visit (40+ min)
51
$13,779
$141
Cyclophosphamide, 100 mg
17
$10,191
—None
New patient visit (45+ min)
43
$6,733
$157
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
11
$5,224
$80
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
35
$5,167
$75
New patient visit (60+ min)
25
$4,985
$199
Injection of additional new drug or substance into vein
69
$4,789
$24
Administration of additional new drug or substance into vein, 1 hour or less
29
$3,568
$67
Injection, zoledronic acid, 1 mg
16
$3,360
—None
Injection of drug or substance under skin or into muscle
36
$2,794
$27
Short return visit (20+ min)
28
$2,323
$61
Administration of chemotherapy into vein, each additional hour
36
$2,276
$30
Biopsy of bone marrow
13
$2,265
$174
Injection of drug or substance into vein
18
$1,838
$61
Administration of additional new drug or substance into vein using push technique
14
$1,536
$67
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
14
$1,104
$19
Collection of blood sample from implanted device
14
$856
$26
Infusion into a vein for hydration, each additional hour
12
$806
$16
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
11
$702
$32
Transfusion of blood or blood products
14
$615
$38
Office for the evaluation and management of established patient that may not require presence of healthcare professional
22
$557
$21
Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service
12
$149
$12
Injection, dexamethasone sodium phosphate, 1 mg
52
$115
—None
Injection, ondansetron hydrochloride, per 1 mg
35
$61
—None
Infusion, normal saline solution, 250 cc
13
$33
—None
Injection, diphenhydramine hcl, up to 50 mg
26
$18
—None
2014: 29 services
Original Medicare services billed in 2014
Injection, rituximab, 100 mg
13
$86,163
—None
Injection, infliximab, excludes biosimilar, 10 mg
17
$58,043
—None
Return visit (30+ min)
218
$49,453
$90
Administration of chemotherapy into vein, 1 hour or less
77
$19,824
$136
Long return visit (40+ min)
54
$13,927
$127
Cyclophosphamide, 100 mg
11
$9,579
—None
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
12
$9,173
$75
Short return visit (20+ min)
77
$7,242
$63
Injection, zoledronic acid, 1 mg
12
$5,965
—None
New patient visit (45+ min)
41
$5,946
$145
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
33
$5,748
$70
New patient visit (60+ min)
20
$3,768
$188
Injection of additional new drug or substance into vein
52
$3,739
$22
Injection of drug or substance under skin or into muscle
31
$3,246
$25
Administration of additional new drug or substance into vein using push technique
16
$2,802
$62
Administration of additional new drug or substance into vein, 1 hour or less
22
$2,706
$63
Administration of chemotherapy into vein, each additional hour
38
$2,249
$28
Biopsy of bone marrow
11
$1,858
$155
Injection of drug or substance into vein
18
$1,828
$55
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
17
$1,141
$30
Transfusion of blood or blood products
15
$679
$32
Collection of blood sample from implanted device
12
$558
$24
Office for the evaluation and management of established patient that may not require presence of healthcare professional
22
$422
$18
Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service
11
$141
$12
Injection, dexamethasone sodium phosphate, 1 mg
42
$115
—None
Injection, ondansetron hydrochloride, per 1 mg
36
$86
—None
Injection, furosemide, up to 20 mg
12
$65
—None
Infusion, normal saline solution, 250 cc
11
$35
—None
Injection, diphenhydramine hcl, up to 50 mg
16
$16
—None
2013: 16 services
Original Medicare services billed in 2013
Return visit (30+ min)
202
$47,421
$92
Injection, infliximab, excludes biosimilar, 10 mg
12
$30,874
—None
Administration of chemotherapy into vein, 1 hour or less
46
$15,433
$147
Long return visit (40+ min)
37
$10,048
$129
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
12
$6,735
$77
New patient visit (60+ min)
25
$4,670
$187
New patient visit (45+ min)
29
$4,048
$140
Short return visit (20+ min)
38
$3,245
$66
Injection of drug or substance under skin or into muscle
19
$2,431
$26
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
19
$2,250
$78
Administration of additional new drug or substance into vein, 1 hour or less
11
$2,112
$73
Injection of additional new drug or substance into vein
23
$2,025
$23
Administration of chemotherapy into vein, each additional hour
19
$1,665
$31
Office for the evaluation and management of established patient that may not require presence of healthcare professional
15
$360
$19
Injection, ondansetron hydrochloride, per 1 mg
16
$74
—None
Injection, dexamethasone sodium phosphate, 1 mg
18
$51
—None
Drugs they prescribed that Part D paid
$1,138,785
Pharmacies billed $1,138,785 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
301 generic and 116 brand-name prescriptions · $1,138,785 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Largest Part D drug costs
Imbruvica
26
$443,508
$17,058
Alecensa
15
$256,383
$17,092
Abiraterone Acetate
13
$34,941
$2,688
Eliquis
22
$22,752
$1,034
Exemestane
58
$16,920
$292
See all 8 drugs
Every Part D drug this clinician prescribed
Imbruvica
26
$443,508
$17,058
Alecensa
15
$256,383
$17,092
Abiraterone Acetate
13
$34,941
$2,688
Eliquis
22
$22,752
$1,034
Exemestane
58
$16,920
$292
Hydroxyurea
42
$1,485
$35
Anastrozole
41
$1,018
$25
Acyclovir
58
$626
$11
Year by year
Part D prescribing by year
2024
417
117
—None
28%
$1,138,785
2023
950
183
1% (13)
25%
$2,307,119
2022
1,180
196
2% (21)
—None
$3,013,940
2021
1,256
192
2% (21)
30%
$3,657,448
2020
1,295
193
2% (30)
26%
$3,046,882
2019
1,113
193
4% (41)
23%
$1,980,423
2018
958
155
3% (33)
19%
$1,681,000
2017
800
128
4% (31)
21%
$1,355,924
2016
759
125
4% (32)
15%
$931,292
2015
708
115
4% (25)
13%
$590,657
2014
666
106
6% (39)
—None
$332,408
2013
612
94
5% (32)
17%
$325,353
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
Part D drugs prescribed in 2023
Imbruvica
46
$755,406
$16,422
Alecensa
21
$366,305
$17,443
Revlimid
14
$286,812
$20,487
Pomalyst
11
$209,387
$19,035
Verzenio
11
$174,313
$15,847
Eliquis
52
$41,513
$798
Abiraterone Acetate
38
$35,233
$927
Exemestane
106
$31,107
$293
Hydroxyurea
104
$6,212
$60
Anastrozole
123
$3,312
$27
Tamoxifen Citrate
31
$1,341
$43
Acyclovir
73
$1,279
$18
Dexamethasone
11
$447
$41
Prednisone
29
$444
$15
Prochlorperazine Maleate
22
$328
$15
Zolpidem
21
$282
$13
Alendronate
16
$207
$13
Lorazepam
30
$181
$6
Gabapentin
12
$146
$12
Furosemide
11
$71
$6
2022: 28 drugs
Part D drugs prescribed in 2022
Imbruvica
56
$846,317
$15,113
Revlimid
34
$591,575
$17,399
Pomalyst
18
$393,317
$21,851
Alecensa
22
$366,969
$16,680
Brukinsa
13
$174,854
$13,450
Sprycel
12
$56,434
$4,703
Pegasys
13
$47,290
$3,638
Eliquis
57
$35,796
$628
Abiraterone Acetate
33
$24,688
$748
Exemestane
91
$23,316
$256
Hydroxyurea
123
$7,345
$60
Imatinib Mesylate
11
$3,031
$276
Anastrozole
119
$2,935
$25
Acyclovir
83
$1,146
$14
Tamoxifen Citrate
42
$937
$22
Letrozole
18
$923
$51
Prochlorperazine Maleate
37
$696
$19
Dexamethasone
25
$692
$28
Methotrexate
11
$505
$46
Zolpidem
43
$443
$10
Prednisone
45
$363
$8
Lorazepam
44
$225
$5
Ondansetron
23
$215
$9
Allopurinol
11
$184
$17
Alendronate
21
$174
$8
Gabapentin
16
$140
$9
Trazodone
11
$98
$9
Furosemide
12
$59
$5
2021: 31 drugs
Part D drugs prescribed in 2021
Imbruvica
75
$1,095,063
$14,601
Revlimid
39
$605,099
$15,515
Alecensa
23
$366,837
$15,949
Pomalyst
16
$294,087
$18,380
Cabometyx
11
$242,490
$22,045
Erleada
13
$178,511
$13,732
Xtandi
12
$157,229
$13,102
Bosulif
11
$112,045
$10,186
Sprycel
13
$58,504
$4,500
Pegasys
11
$54,968
$4,997
Eliquis
61
$42,411
$695
Abiraterone Acetate
45
$31,247
$694
Venclexta
12
$30,163
$2,514
Exemestane
87
$30,066
$346
Hydroxyurea
165
$9,301
$56
Xarelto
12
$7,548
$629
Imatinib Mesylate
11
$4,042
$367
Anastrozole
93
$3,904
$42
Tamoxifen Citrate
54
$1,453
$27
Letrozole
17
$868
$51
Dexamethasone
42
$864
$21
Acyclovir
51
$830
$16
Prochlorperazine Maleate
44
$689
$16
Prednisone
69
$547
$8
Ondansetron
18
$310
$17
Methotrexate
12
$304
$25
Allopurinol
13
$170
$13
Lorazepam
38
$154
$4
Alendronate
19
$131
$7
Omeprazole
11
$128
$12
Zolpidem
13
$46
$4
2020: 29 drugs
Part D drugs prescribed in 2020
Revlimid
52
$809,342
$15,564
Imbruvica
50
$761,717
$15,234
Ibrance
25
$313,851
$12,554
Pomalyst
20
$298,473
$14,924
Xtandi
12
$148,238
$12,353
Abiraterone Acetate
36
$94,366
$2,621
Bosulif
11
$84,052
$7,641
Pegasys
11
$44,186
$4,017
Exemestane
107
$43,650
$408
Venclexta
15
$37,583
$2,506
Eliquis
41
$25,680
$626
Xarelto
22
$13,205
$600
Anagrelide
18
$11,906
$661
Hydroxyurea
156
$9,188
$59
Imatinib Mesylate
17
$7,134
$420
Anastrozole
119
$4,146
$35
Tamoxifen Citrate
54
$2,091
$39
Dexamethasone
45
$1,073
$24
Acyclovir
84
$1,056
$13
Letrozole
13
$740
$57
Prochlorperazine Maleate
40
$597
$15
Bicalutamide
18
$593
$33
Ondansetron
28
$393
$14
Prednisone
57
$373
$7
Alendronate
20
$269
$13
Lorazepam
38
$215
$6
Omeprazole
14
$149
$11
Gabapentin
15
$139
$9
Zolpidem
15
$50
$3
2019: 22 drugs
Part D drugs prescribed in 2019
Revlimid
66
$977,367
$14,809
Imbruvica
26
$415,561
$15,983
Bosulif
11
$76,944
$6,995
Abiraterone Acetate
19
$74,603
$3,926
Imatinib Mesylate
18
$63,000
$3,500
Exemestane
133
$44,856
$337
Eliquis
34
$26,419
$777
Enoxaparin
15
$6,149
$410
Anagrelide
14
$5,124
$366
Hydroxyurea
95
$4,543
$48
Anastrozole
139
$3,104
$22
Tamoxifen Citrate
59
$2,680
$45
Dexamethasone
51
$1,369
$27
Acyclovir
62
$1,221
$20
Bicalutamide
18
$579
$32
Prochlorperazine Maleate
48
$439
$9
Gabapentin
11
$346
$31
Alendronate
24
$233
$10
Lorazepam
38
$217
$6
Prednisone
33
$194
$6
Ondansetron
18
$160
$9
Zolpidem
12
$65
$5
2018: 21 drugs
Part D drugs prescribed in 2018
Revlimid
49
$701,883
$14,324
Imbruvica
14
$164,818
$11,773
Sprycel
13
$145,152
$11,166
Zytiga
12
$121,395
$10,116
Xtandi
11
$119,588
$10,872
Votrient
12
$76,352
$6,363
Exemestane
88
$42,754
$486
Hydroxyurea
126
$4,945
$39
Anagrelide
12
$3,829
$319
Anastrozole
161
$2,572
$16
Tamoxifen Citrate
39
$1,993
$51
Dexamethasone
36
$1,141
$32
Famciclovir
12
$736
$61
Acyclovir
33
$663
$20
Oxycodone-Acetaminophen
11
$478
$43
Ondansetron
25
$300
$12
Prochlorperazine Maleate
36
$270
$7
Lorazepam
55
$227
$4
Prednisone
20
$206
$10
Zolpidem
16
$154
$10
Alendronate
12
$119
$10
2017: 18 drugs
Part D drugs prescribed in 2017
Revlimid
24
$306,741
$12,781
Imbruvica
23
$237,534
$10,328
Sprycel
19
$201,631
$10,612
Zytiga
22
$184,078
$8,367
Tarceva
12
$101,424
$8,452
Exemestane
71
$42,173
$594
Hydroxyurea
109
$3,447
$32
Anastrozole
115
$1,828
$16
Tamoxifen Citrate
33
$1,523
$46
Anagrelide
19
$1,357
$71
Acyclovir
21
$570
$27
Dexamethasone
27
$419
$16
Lorazepam
49
$310
$6
Bicalutamide
17
$258
$15
Ondansetron
14
$224
$16
Prednisone
24
$219
$9
Prochlorperazine Maleate
22
$148
$7
Zolpidem
14
$63
$4
2016: 19 drugs
Part D drugs prescribed in 2016
Revlimid
25
$264,120
$10,565
Imbruvica
22
$239,944
$10,907
Xtandi
12
$111,178
$9,265
Exemestane
62
$29,020
$468
Hydroxyurea
90
$2,473
$27
Tamoxifen Citrate
52
$1,263
$24
Anastrozole
59
$1,202
$20
Famciclovir
21
$991
$47
Anagrelide
11
$610
$55
Dexamethasone
34
$536
$16
Lorazepam
67
$521
$8
Bicalutamide
22
$516
$23
Acyclovir
27
$415
$15
Ondansetron
22
$327
$15
Gabapentin
16
$245
$15
Prochlorperazine Maleate
24
$164
$7
Prednisone
16
$118
$7
Alendronate
15
$100
$7
Fluconazole
11
$72
$7
2015: 16 drugs
Part D drugs prescribed in 2015
Revlimid
24
$233,838
$9,743
Sprycel
19
$104,768
$5,514
Zytiga
11
$86,945
$7,904
Exemestane
50
$23,090
$462
Famciclovir
36
$2,379
$66
Hydroxyurea
77
$2,277
$30
Anastrozole
99
$1,878
$19
Tamoxifen Citrate
48
$1,194
$25
Dexamethasone
42
$412
$10
Acyclovir
18
$393
$22
Anagrelide
11
$388
$35
Lorazepam
60
$375
$6
Hydrocodone-Acetaminophen
11
$346
$31
Ondansetron
17
$249
$15
Prednisone
18
$224
$12
Prochlorperazine Maleate
28
$178
$6
2014: 14 drugs
Part D drugs prescribed in 2014
Revlimid
16
$138,081
$8,630
Sprycel
13
$72,370
$5,567
Exemestane
63
$31,473
$500
Anastrozole
105
$3,480
$33
Hydroxyurea
81
$2,663
$33
Famciclovir
32
$1,809
$57
Ketoconazole
12
$1,675
$140
Hydrocodone-Acetaminophen
26
$494
$19
Dexamethasone
43
$473
$11
Tamoxifen Citrate
13
$427
$33
Lorazepam
51
$298
$6
Prochlorperazine Maleate
23
$186
$8
Hydrocortisone
12
$181
$15
Prednisone
16
$170
$11
2013: 14 drugs
Part D drugs prescribed in 2013
Revlimid
15
$122,946
$8,196
Tarceva
13
$76,646
$5,896
Sprycel
13
$60,098
$4,623
Exemestane
56
$23,597
$421
Anastrozole
114
$4,974
$44
Hydroxyurea
71
$2,988
$42
Famciclovir
25
$2,771
$111
Evista
12
$2,154
$180
Dexamethasone
50
$458
$9
Alendronate
16
$267
$17
Lorazepam
39
$170
$4
Hydrocodone-Acetaminophen
30
$159
$5
Diphenoxylate-Atropine
19
$141
$7
Prednisone
18
$49
$3
Money from drug and device companies
$33 in 2025
Industry payments by year
2025
1
1
—None
$33
2023
2
2
—None
$55
2022
1
1
—None
$32
2019
2
2
—None
$24
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.